Maze Therapeutics, Inc.
MAZE
$27.18
-$0.49-1.75%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -84.76% | 29.97% | -14.89% | 10.67% | -2.72% |
| Total Depreciation and Amortization | -11.94% | -11.02% | -12.61% | -12.02% | -5.12% |
| Total Amortization of Deferred Charges | -65.77% | -- | -- | -- | -- |
| Total Other Non-Cash Items | 26.16% | 19.64% | 52.07% | 8.89% | 0.12% |
| Change in Net Operating Assets | 180.75% | -7,512.86% | -162.08% | 148.27% | 27.16% |
| Cash from Operations | 61.51% | -41.05% | -12.53% | 18.00% | -1.82% |
| Capital Expenditure | -15.05% | -173.53% | 50.00% | 82.70% | -31.44% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2,116.32% | 106.16% | -54.69% | -- | -- |
| Cash from Investing | -2,147.90% | 106.07% | -54.58% | -16,918.58% | -31.44% |
| Total Debt Issued | -100.00% | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3,536.99% | 13.62% | -97.50% | 4,597.94% | -97.61% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 18.34% | -- | -- | 100.00% | -389.60% |
| Cash from Financing | 248.08% | 1,079.86% | -97.50% | 23,389.71% | -99.52% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -59.27% | 107.46% | -344.15% | 275.08% | -130.58% |